Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/38877
Tipo
ArtículoDerechos de autor
Acceso abierto
Fecha del embargo
2020-12-27
Colecciones
- INI - Artigos de Periódicos [3397]
Metadatos
Mostrar el registro completo del ítem
CHOLINERGIC STIMULATION IMPROVES AUTONOMIC AND HEMODYNAMIC PROFILE DURING DYNAMIC EXERCISE IN PATIENTS WITH HEART FAILURE
Autor
Afiliación
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil / Rio de Janeiro Federal University. Division of Cardiology. Rio de Janeiro, RJ, Brazil.
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil.
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil.
Rio de Janeiro Federal University. Division of Cardiology. Rio de Janeiro, RJ, Brazil.
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil.
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil.
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil.
Rio de Janeiro Federal University. Division of Cardiology. Rio de Janeiro, RJ, Brazil.
Fluminense Federal University. Department of Physiology and Pharmacology. Niterói, RJ, Brazil / Fluminense Federal University. Post-Graduate Program in Cardiovascular Sciences. Niterói, RJ, Brazil.
Resumen en ingles
Background: Parasympathetic dysfunction is an independent risk factor for mortality in heart failure for which there is no specific pharmacologic treatment. This article aims to determine the effect of pyridostigmine, an anticholinesterase agent, on the integrated physiologic responses to dynamic exercise in heart failure. Methods and Results: Patients with chronic heart failure (n = 23; 9 female; age= 48 +/-12 years) were submitted to 3 maximal cardiopulmonary exercise tests on treadmill in different days. The first test was used for adaptation and to determine exercise tolerance. The other tests were performed after oral administration of pyridostigmine (45 mg, 3 times/day, for 24 hours) or placebo, in random order. All patients were taking their usual medication. Pyridostigmine reduced cholinesterase activity by 30%, inhibitedthe chronotropic response throughout exercise, up to 60% of maximal effort (pyridostigmine510863 beats/min vs. placebo = 113 +/- 3 beats/min; P = .040), and improved heart rate reserve (pyridostigmine = 73 +/- 5 beats/min vs. placebo = 69 +/- 5 beats/min; P = 0.035) and heart rate recovery in the first minute after exercise (pyridostigmine = 25 +/- 2 beats/min vs. placebo = 22 +/- 2 beats/min; P = .005), whereas peak heart rate was similar to placebo. Oxygen pulse, an indirect indicator of stroke volume, was higher under pyridostigmine during submaximal exercise. Conclusions: Pyridostigmine was well tolerated by heart failure patients, leading to improved hemoynamic profile during dynamic exercise.
Compartir